Meridian Bioscience (VIVO) Reports In-Line Q1 EPS
Get Alerts VIVO Hot Sheet
Price: $33.97 --0%
Revenue Growth %: -100.0%
Financial Fact:
Common share options: -897K
Today's EPS Names:
FSI, RELV, NEOM, More
Revenue Growth %: -100.0%
Financial Fact:
Common share options: -897K
Today's EPS Names:
FSI, RELV, NEOM, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $47.2 million versus the consensus estimate of $48.6 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2 reasons why Tesla stock fell on Thursday
- P3 Health Partners Inc. (PIII) Misses Q4 EPS by 14c, reaffirms guidance
- NaaS Technology Inc. (NAAS) Reports Q1 Loss of $0.29
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!